Company: ShiftBio

Job title: Director, Principal & Researcher


Maximizing Intracellular Delivery by Fusogenic Intrinsic Nanovesicles 1:30 pm

Fusosome platform can specifically fuse to the surface of target cells Fusosome is a platform technology that facilitates membrane-editing and direct delivery of therapeutic cargos into the target cell cytoplasm We reappraised the idea that extracellular vesicles function as garbage cans and repurposed them as a therapeutic agentRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.